{"id":135018,"date":"2025-11-12T11:29:39","date_gmt":"2025-11-12T10:29:39","guid":{"rendered":"https:\/\/www.bcfi.be\/?post_type=avada_portfolio&#038;p=135018"},"modified":"2026-02-18T12:39:10","modified_gmt":"2026-02-18T11:39:10","slug":"insuffisance-renale-chronique-ralentir-la-maladie-avec-les-medicaments-nephroprotecteurs","status":"publish","type":"avada_portfolio","link":"https:\/\/cbip.be\/fr\/portfolio\/insuffisance-renale-chronique-ralentir-la-maladie-avec-les-medicaments-nephroprotecteurs\/","title":{"rendered":"Insuffisance r\u00e9nale chronique &#8211; Ralentir la maladie avec les m\u00e9dicaments n\u00e9phroprotecteurs"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>Dans votre pratique, vous suivez r\u00e9guli\u00e8rement des patients atteints d\u2019insuffisance r\u00e9nale chronique (IRC), une maladie fr\u00e9quente. Les patients en IRC demandent des soins complexes : ils souffrent g\u00e9n\u00e9ralement de plusieurs maladies et sont souvent polym\u00e9diqu\u00e9s. La gestion de leur traitement m\u00e9dicamenteux est donc un exercice difficile.<\/p>\n<p>Deux objectifs importants du traitement de l\u2019IRC sont\u00a0de ralentir la d\u00e9t\u00e9rioration de la fonction r\u00e9nale et de r\u00e9duire le risque cardiovasculaire. Il peut en r\u00e9sulter une diff\u00e9rence consid\u00e9rable tant au niveau de l&rsquo;esp\u00e9rance de vie que de la qualit\u00e9 de vie de votre patient.<\/p>\n<p>Dans cet e-learning, nous nous concentrons sur les m\u00e9dicaments permettant de ralentir la progression de l&rsquo;insuffisance r\u00e9nale chronique.<\/p>\n<ul>\n<li>Quand les initier ?<\/li>\n<li>Comment les doser correctement ?<\/li>\n<li>Et \u00e0 quoi faire attention pendant leur suivi ?<\/li>\n<\/ul>\n<p>Quelques bases vous sont \u00e9galement donn\u00e9es pour vous familiariser avec la prise en charge globale de ces patients.<\/p>\n<p>Cet e-learning n\u2019aborde pas la prise en charge de l&rsquo;insuffisance r\u00e9nale <em>terminale<\/em>, qui rel\u00e8ve plut\u00f4t de la comp\u00e9tence du n\u00e9phrologue.<\/p>\n<p>Ce module s&rsquo;adresse surtout aux m\u00e9decins. Les pharmaciens int\u00e9ress\u00e9s par le traitement de l&rsquo;insuffisance r\u00e9nale peuvent bien entendu le suivre, mais ce module ne propose pas de conseils utiles \u00e0 la pratique du pharmacien.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#9201; <b>XL &#8211; 1 heure<\/b><br \/>Quand initier ces m\u00e9dicaments ? Comment les doser correctement ? Et \u00e0 quoi faire attention pendant leur suivi ?<br \/><b>M\u00e9decins: 1 CP, Pharmacien d&rsquo;officine: 2 CP, Pharmacien hospitalier: 2 CP<\/b><br \/>&#9202; novembre 2025<\/p>\n","protected":false},"author":3,"featured_media":135022,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"footnotes":""},"portfolio_category":[30,32],"portfolio_skills":[143,145,147],"portfolio_tags":[20345],"class_list":["post-135018","avada_portfolio","type-avada_portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-pour-les-medecins","portfolio_category-pour-les-pharmaciens","portfolio_skills-medecin-1-cp","portfolio_skills-pharmacien-dofficine-2-cp","portfolio_skills-pharmacien-hospitalier-2-cp","portfolio_tags-insuffisance-renale"],"_links":{"self":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/135018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=135018"}],"version-history":[{"count":7,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/135018\/revisions"}],"predecessor-version":[{"id":174912,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/135018\/revisions\/174912"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media\/135022"}],"wp:attachment":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=135018"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_category?post=135018"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_skills?post=135018"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_tags?post=135018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}